As part of its ongoing effort to speed-up the response to the COVID-19 epidemic, the Bill and Melinda Gates Foundation is funding a new initiative dedicated to identifying, assessing, developing, and scaling-up treatments for the virus.
The newly-formulated COVID-19 Therapeutics Accelerator—which is being funded by The Gates Foundation, London-based research charity Wellcome, and Mastercard—will play a catalytic role in accelerating and evaluating new and repurposed drugs and biologics to treat patients with COVID-19 in the immediate term, and other viral pathogens in the longer-term.
The Gates Foundation and Wellcome are each contributing up to $50 million, while the Mastercard Impact Fund has committed up to $25 million to catalyze the initial work of the accelerator. The Gates Foundation’s funding is part of its up to $100 million commitment to the COVID-19 response announced last month.
Read more about this amazing story here!
